Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk

Matthews, Philippa C; Ocama, Ponsiano; Wang, Su; El-Sayed, Manal; Turkova, Anna; Ford, Deborah; Torimiro, Judith; ... Hamid, Saeed; + view all (2023) Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk. JHEP Reports , 5 (11) , Article 100875. 10.1016/j.jhepr.2023.100875. Green open access

[thumbnail of 1-s2.0-S2589555923002069-main.pdf]

Preview

Text
1-s2.0-S2589555923002069-main.pdf - Published Version
Download (378kB) | Preview

Type:	Article
Title:	Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1016/j.jhepr.2023.100875
Publisher version:	https://doi.org/10.1016/j.jhepr.2023.100875
Language:	English
Additional information:	This is an open access article under the CC BY-NC-ND license https://creativecommons.org/licenses/by-nc-nd/4.0/
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
URI:	https://discovery.ucl.ac.uk/id/eprint/10178821